FirstRanker Logo

FirstRanker.com - FirstRanker's Choice is a hub of Question Papers & Study Materials for B-Tech, B.E, M-Tech, MCA, M.Sc, MBBS, BDS, MBA, B.Sc, Degree, B.Sc Nursing, B-Pharmacy, D-Pharmacy, MD, Medical, Dental, Engineering students. All services of FirstRanker.com are FREE

📱

Get the MBBS Question Bank Android App

Access previous years' papers, solved question papers, notes, and more on the go!

Install From Play Store

Download DNB 2020 June Medical Oncology Paper III Question Paper

Download Diplomate of National Board (DNB) 2020 June Medical Oncology Paper III Question Paper

This post was last modified on 31 July 2021

FINAL EXAM
NATIONAL BOARD OF EXAMINATIONS
JUNE 2020
MEDICAL ONCOLOGY
PAPER-III

--- Content provided by FirstRanker.com ---

Time: 3 hours
MEDONCO/J/20/17/III
Max. Marks:100
Important Instructions:
Attempt al questions in order.

--- Content provided by‌ FirstRanker.com ---

Each question carries 10 marks.
Read the question careful y and answer to the point neatly and legibly.
Do not leave any blank pages between two answers.
Indicate the question number correctly for the answer in the margin space.
Answer all the parts of a single question together.

--- Content provided by FirstRanker.com ---

Start the answer to a question on a fresh page or leave adequate space between two answers.
Draw table/diagrams/flowcharts wherever appropriate.
Write short notes on:
1. a) Pathobiology of radiotherapy.
3+4+3

--- Content provided by FirstRanker.com ---

b) Newer techniques of radiotherapy in CNS tumors.
c) What are radiation sensitizers?
2. a) Epidemiology of nasopharyngeal carcinoma.
2+4+4
b) Staging of nasopharyngeal carcinoma.

--- Content provided by⁠ FirstRanker.com ---

c) Treatment of nasopharyngeal carcinoma.
3. a) Information technology and cancer care.
4+3+3
b) Chemo-informatics.
c) Online predictive tools in oncology practice.

--- Content provided by‌ FirstRanker.com ---

4. a) What are prognostic and predictive biomarkers in CLL?
3+3+4
b) List the small molecule inhibitors in CLL.
c) Mention special considerations in their usage.
5. a) Neuro-diagnostic imaging in CNS tumors.

--- Content provided by‌ FirstRanker.com ---

3+3+4
b) Cytogenetic and molecular diagnostics of CNS gliomas.
c) Targeted treatment of CNS gliomas.
6. a) Classification of malignant melanoma.
2+4+4

--- Content provided by​ FirstRanker.com ---

b) Treatment of metastatic melanoma.
c) Enumerate complications of immunotherapy.
7. a) Interventional procedures in the evaluation of mediastinal
3+4+3
lymphadenopathy.

--- Content provided by FirstRanker.com ---

b) Treatment of Stage III inoperable squamous cell ?NSCLC.
c) Paraneoplastic syndromes in lung cancer.
8. a) Combined treatment modalities of a rectal cancer.
4+2+4
b) What are the complications of surgery in rectal cancers?

--- Content provided by‌ FirstRanker.com ---

c) Risk reduction surgery in gastrointestinal malignancies.
P.T.O.
-1-
POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINATION HALL.

--- Content provided by‌ FirstRanker.com ---


FINAL EXAM
NATIONAL BOARD OF EXAMINATIONS
JUNE 2020
MEDICAL ONCOLOGY
PAPER-III

--- Content provided by⁠ FirstRanker.com ---

9. a) Staging
and
risk
stratification
of

--- Content provided by‍ FirstRanker.com ---

gestational
trophoblastic
3+4+3
neoplasm(GTN).
b) Treatment of GTN.

--- Content provided by‌ FirstRanker.com ---

c) Role of Gynae-oncologist and surveil ance in GTN.
10. a) Pros and cons of neo-adjuvant chemotherapy in head and neck
4+3+3
squamous cell carcinoma (HNSCC).
b) Indications of preoperative and post-operative RT in HNSCC.

--- Content provided by‌ FirstRanker.com ---

c) Prevention and management of RT associated xerostomia.
************
-2-
POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINATION HALL.

--- Content provided by‌ FirstRanker.com ---